These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Diltiazem (0.5 mg/l) decreases coronary vascular resistance during reperfusion, but not during low flow ischemia, in the isolated perfused rat heart.
    Author: Mohanlal RW, Wijnmaalen P, Mauve I, Zeeuwe P, van der Laarse A.
    Journal: Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):3-11. PubMed ID: 2916080.
    Abstract:
    Isolated rat hearts underwent low flow perfusion with a perfusion pressure of 15 mmHg for two hours followed by reperfusion at a perfusion pressure of 80 mmHg for two hours. In these severely damaged hearts we tested whether diltiazem (0.5 mg/l) administered during ischemia or during reperfusion had vasodilatory effects. Ischemia-induced progressive vasoconstriction was not influenced by the presence of diltiazem: during ischemia coronary vascular resistance (CVR) rose from 3.3 +/- 0.1 to 46.4 +/- 17.6 mmHg.ml-1.min in the diltiazem group and from 3.5 +/- 0.1 to 42.4 +/- 5.3 mmHg.ml-1.min in the control group (n.s.). If diltiazem was administered during reperfusion only CVR dropped from 45.7 +/- 9.2 to 4.4 +/- 1.1 mmHg.ml-1.min in the presence of diltiazem, and from 47.1 +/- 11.6 to 9.3 +/- 1.5 mmHg.ml-1.min in the control group (P less than 0.025). The disparity between diltiazem's effects during ischemia and reperfusion suggests a different mechanism of Ca2+-influx in vascular smooth muscle cells in ischemic and reperfused hearts: in reperfusion through the Ca2+-channels which are sensitive to calcium antagonists, and in ischemia through other channels, like the Na+/Ca2+ exchanger, or from intracellular calcium stores.
    [Abstract] [Full Text] [Related] [New Search]